De Rossi, P;
Lewis, AJ;
Furrer, J;
De Vos, L;
Demeter, T;
Zbinden, A;
Zhong, W;
... Polymenidou, M; + view all
(2021)
FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade.
EMBO Reports
, Article e53877. 10.15252/embr.202153877.
(In press).
Preview |
Text
Lashley_FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade_VoR.pdf - Published Version Download (5MB) | Preview |
Abstract
Morphologically distinct TDP-43 aggregates occur in clinically different FTLD-TDP subtypes, yet the mechanism of their emergence and contribution to clinical heterogeneity are poorly understood. Several lines of evidence suggest that pathological TDP-43 follows a prion-like cascade, but the molecular determinants of this process remain unknown. We use advanced microscopy techniques to compare the seeding properties of pathological FTLD-TDP-A and FTLD-TDP-C aggregates. Upon inoculation of patient-derived aggregates in cells, FTLD-TDP-A seeds amplify in a template-dependent fashion, triggering neoaggregation more efficiently than those extracted from FTLD-TDP-C patients, correlating with the respective disease progression rates. Neoaggregates are sequentially phosphorylated with N-to-C directionality and with subtype-specific timelines. The resulting FTLD-TDP-A neoaggregates are large and contain densely packed fibrils, reminiscent of the pure compacted fibrils present within cytoplasmic inclusions in postmortem brains. In contrast, FTLD-TDP-C dystrophic neurites show less dense fibrils mixed with cellular components, and their respective neoaggregates are small, amorphous protein accumulations. These cellular seeding models replicate aspects of the patient pathological diversity and will be a useful tool in the quest for subtype-specific therapeutics.
Type: | Article |
---|---|
Title: | FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.15252/embr.202153877 |
Publisher version: | https://doi.org/10.15252/embr.202153877 |
Language: | English |
Additional information: | © 2021 The Authors. Published under the terms of the CC BY NC ND 4.0 license This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10139520 |
Archive Staff Only
View Item |